Corporate Status Notice
Last updated: July 2026
Corporate Status Notice
İKRA Biotechnologies is an independent biotechnology project development venture focused on international technology, investment, licensing and partnership opportunities.
The company does not currently:
- operate a biotechnology or pharmaceutical manufacturing facility,
- manufacture plasma-derived medicinal products or other biologics,
- own or license a commercial plasma fractionation technology,
- hold a medicinal product manufacturing authorisation,
- hold a marketing authorisation for any medicinal product,
- or act as an authorised distributor of medicinal products.
The areas described on this website represent the company's current interests, research activities, stakeholder discussions and potential project development objectives.
All future projects would remain subject to feasibility assessment, financing, scientific and technical evaluation, due diligence, contractual agreement and approval by the relevant authorities.
Legal Disclaimer
The information provided on this website is intended solely for general corporate and informational purposes.
Nothing on this website constitutes:
- a medicinal product advertisement,
- medical or scientific advice,
- legal or regulatory advice,
- an investment recommendation,
- a public offering,
- a securities solicitation,
- a binding partnership proposal,
- a technology licence,
- a representation of regulatory approval,
- or a commitment to establish or operate a manufacturing facility.
Statements concerning possible future projects, partnerships, products, technologies or investments represent current areas of interest and intention only. They should not be interpreted as a guarantee that any such activity will be implemented.
All potential collaborations and projects are subject to separate evaluation, scientific and technical assessment, due diligence, confidentiality arrangements, internal approvals and definitive written agreements.